With confluency in differentiating Caco-2 cells, we investigated the relationship between GSTA1 and order 79983-71-4 cellular proliferation. For this purpose, we transiently modulated GSTA1 expression levels in preconfluent cells and confirmed GSTA1 down-regulation or over-expression by western blot analysis and enzyme activity (Figure 2 and Table 1). Preconfluent cells were transiently transfected with GSTA1 siRNA and non-specific negative control (NS) siRNA for 72 h to down-regulate GSTA1 (Fig. 2A). The Lixisenatide protein levels significantly decreased by 68 (p,0.001) in GSTA1 siRNAtransfected cells as compared to controls (Fig. 2A and Table 1).SDS-PAGE and Western blot analysisCaspase-3, p-JNK and GSTA1 and GSTP1 expression were assessed by western blot analysis. Cells were harvested with lysis buffer and stored at 280uC. The cell extracts were then thawed and sonicated on ice for 10 minutes and centrifuged at 9000 rpmGSTA1 and Caco-2 Cell ProliferationFigure 1. GSTA1 levels increase in differentiating Caco-2 cells. Preconfluent and 10 d postconfluent Caco-2 cells were assessed for: (A) protein expression of GSTA1 (,25 KDa) and GSTP1 (,26 KDa). b-actin was used as a protein loading control; (B) GSTA1 enzyme activity (nmol/mg/ min); (C) mRNA levels of differentiation markers: AlkP, villin, DPP-4 and E-cadherin by real time RT-PCR; and (D) AlkP enzyme activity (mmol/mg/min). Values represent the mean 6 S.E. of three independent 23408432 experiments with three replicates each. Bars indicated by different letters differ significantly from one another (p#0.001). doi:10.1371/journal.pone.0051739.gPreconfluent cells were transiently transfected with a GSTA1-V5 expression plasmid and empty vector (EV) for 48 h to overexpress GSTA1. Western blot analysis of transfected cells using an anti-V5 antibody confirmed that expression of GSTA1-V5 occurred only in GSTA1-V5-ransfected cells and was absent in EV-transfected cells (Fig. 2B). In cells transiently transfected with GSTA1-V5, total GSTA1 activity increased 3.5-fold (p,0.001) from 2.8 nmol/ mg/min in cells transfected with EV to 9.9 nmol/mg/min (Table 1). To examine the effect of GSTA1 knockdown or over-expression on cellular proliferation, a MTS assay was performed for up to 72 h (Fig. 3A and B). GSTA1 knockdown significantly increasedcell proliferation at 24 (p,0.05), 48 (p,0.01) and 72 h (p,0.01) as compared to controls (Fig. 3A). In Caco-2 cells overexpressing GSTA1, a significant decrease in proliferation at 48 h (p,0.05) and 72 h (p,0.01) was observed when compared to controls (Fig. 3B). Similar results were obtained when cells were labeled using bromodeoxyuridine (BrdU). BrdU incorporation decreased significantly to 54 of control levels in cells overexpressing GSTA1 (Fig. 3C). No significant increase in cytotoxicity was observed due to transfections in GSTA1 knock-down or overexpressed Caco-2 cells (data not shown).GSTA1 and Caco-2 Cell ProliferationGSTA1 activity is altered with NaB-mediated changes in cell cycle phaseSince GSTA1 modulation affected cellular proliferation and induced changes in cell cycle phase distribution, we further investigated the relationship between GSTA1 expression and transition through various cellular states in cells treated with NaB. Two concentrations of NaB that are known to cause either cellular differentiation (1 mM) or apoptosis (10 mM) were used. To determine the effect of NaB on cellular proliferation, a MTS assay was performed on preconfluent Caco-2 cells treated with NaB (1 and 10 m.With confluency in differentiating Caco-2 cells, we investigated the relationship between GSTA1 and cellular proliferation. For this purpose, we transiently modulated GSTA1 expression levels in preconfluent cells and confirmed GSTA1 down-regulation or over-expression by western blot analysis and enzyme activity (Figure 2 and Table 1). Preconfluent cells were transiently transfected with GSTA1 siRNA and non-specific negative control (NS) siRNA for 72 h to down-regulate GSTA1 (Fig. 2A). The protein levels significantly decreased by 68 (p,0.001) in GSTA1 siRNAtransfected cells as compared to controls (Fig. 2A and Table 1).SDS-PAGE and Western blot analysisCaspase-3, p-JNK and GSTA1 and GSTP1 expression were assessed by western blot analysis. Cells were harvested with lysis buffer and stored at 280uC. The cell extracts were then thawed and sonicated on ice for 10 minutes and centrifuged at 9000 rpmGSTA1 and Caco-2 Cell ProliferationFigure 1. GSTA1 levels increase in differentiating Caco-2 cells. Preconfluent and 10 d postconfluent Caco-2 cells were assessed for: (A) protein expression of GSTA1 (,25 KDa) and GSTP1 (,26 KDa). b-actin was used as a protein loading control; (B) GSTA1 enzyme activity (nmol/mg/ min); (C) mRNA levels of differentiation markers: AlkP, villin, DPP-4 and E-cadherin by real time RT-PCR; and (D) AlkP enzyme activity (mmol/mg/min). Values represent the mean 6 S.E. of three independent 23408432 experiments with three replicates each. Bars indicated by different letters differ significantly from one another (p#0.001). doi:10.1371/journal.pone.0051739.gPreconfluent cells were transiently transfected with a GSTA1-V5 expression plasmid and empty vector (EV) for 48 h to overexpress GSTA1. Western blot analysis of transfected cells using an anti-V5 antibody confirmed that expression of GSTA1-V5 occurred only in GSTA1-V5-ransfected cells and was absent in EV-transfected cells (Fig. 2B). In cells transiently transfected with GSTA1-V5, total GSTA1 activity increased 3.5-fold (p,0.001) from 2.8 nmol/ mg/min in cells transfected with EV to 9.9 nmol/mg/min (Table 1). To examine the effect of GSTA1 knockdown or over-expression on cellular proliferation, a MTS assay was performed for up to 72 h (Fig. 3A and B). GSTA1 knockdown significantly increasedcell proliferation at 24 (p,0.05), 48 (p,0.01) and 72 h (p,0.01) as compared to controls (Fig. 3A). In Caco-2 cells overexpressing GSTA1, a significant decrease in proliferation at 48 h (p,0.05) and 72 h (p,0.01) was observed when compared to controls (Fig. 3B). Similar results were obtained when cells were labeled using bromodeoxyuridine (BrdU). BrdU incorporation decreased significantly to 54 of control levels in cells overexpressing GSTA1 (Fig. 3C). No significant increase in cytotoxicity was observed due to transfections in GSTA1 knock-down or overexpressed Caco-2 cells (data not shown).GSTA1 and Caco-2 Cell ProliferationGSTA1 activity is altered with NaB-mediated changes in cell cycle phaseSince GSTA1 modulation affected cellular proliferation and induced changes in cell cycle phase distribution, we further investigated the relationship between GSTA1 expression and transition through various cellular states in cells treated with NaB. Two concentrations of NaB that are known to cause either cellular differentiation (1 mM) or apoptosis (10 mM) were used. To determine the effect of NaB on cellular proliferation, a MTS assay was performed on preconfluent Caco-2 cells treated with NaB (1 and 10 m.